US Food and Drug Administration Support for Oncology Drug Development During COVID-19.

Kadakia, Kushal T; Pazdur, Richard; Shah, Anand

Kadakia, Kushal T; Pazdur, Richard; Shah, Anand.

Kadakia KT; US Food and Drug Administration, Silver Spring, Maryland.
Pazdur R; US Food and Drug Administration, Silver Spring, Maryland.
Shah A; US Food and Drug Administration, Silver Spring, Maryland.

JAMA Oncol ; 7(1): 27-28, 2021 01 01.

Article in English | MEDLINE | ID: covidwho-839835

Subject(s)

Antineoplastic Agents; COVID-19/epidemiology; Clinical Trials as Topic/methods; Drug Development/methods; Humans; Neoplasms/drug therapy; Pandemics; SARS-CoV-2/isolation & purification; United States; United States Food and Drug Administration

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / Drug Development / COVID-19 / Antineoplastic Agents Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Oncol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google